Abstract: This article provides a comprehensive 2025 market overview of PT-141 peptide, focusing on its composition as a synthetic melanocortin receptor agonist. It analyzes industry growth prospects driven by rising demand in sexual health and research applications. Key research data highlights efficacy and safety profiles, while product comparisons evaluate purity, formulation, and supplier reliability. A selection guide offers criteria for researchers and buyers, including dosage, storage, and regulatory considerations. Essential industry knowledge on synthesis, quality control, and market trends is also summarized to support informed decision-making.
Target Keyword: pt 141 peptide
PT-141 peptide, also known as Bremelanotide, is a synthetic cyclic heptapeptide that functions as a melanocortin receptor agonist, specifically targeting the MC3R and MC4R subtypes. This compound is distinct from traditional peptides due to its unique mechanism of action, which bypasses the vascular system to directly influence central nervous system pathways. For B2B buyers, including cosmetic formulators, research laboratories, and bulk raw material distributors, understanding the precise technical specifications is critical for ensuring product efficacy and regulatory compliance. The core value of PT-141 lies in its high specificity and stability, making it a preferred choice for advanced research applications in sexual health and metabolic studies.
Industry data from 2024 indicates that the global PT-141 peptide market is projected to grow at a CAGR of 8.5% through 2030, driven by increasing demand in sexual health research and metabolic disorder studies. Over 70% of bulk buyers prioritize purity certification and third-party testing when selecting suppliers.
The production of PT-141 peptide involves solid-phase peptide synthesis (SPPS) using Fmoc chemistry, followed by cyclization to achieve the active cyclic structure. This process requires precise control of reaction conditions to minimize by-products and ensure batch-to-batch consistency. After synthesis, the crude peptide undergoes purification via preparative HPLC, achieving the target purity level. Quality control is a multi-step process that includes mass spectrometry (MS) for molecular weight confirmation, amino acid analysis for composition verification, and HPLC for purity assessment. Reputable manufacturers also conduct endotoxin testing and sterility tests for injectable-grade products. For B2B buyers, requesting a Certificate of Analysis (CoA) is essential to verify these parameters.
PT-141 peptide is primarily utilized in research and development settings, with limited direct cosmetic applications due to its systemic mechanism. In cosmetic formulation, it is explored for topical applications targeting skin pigmentation disorders, leveraging its melanocortin receptor activity to stimulate melanogenesis. However, most commercial demand comes from laboratory research, where it is used to study sexual dysfunction, erectile dysfunction, and female sexual arousal disorder in animal models. Bulk wholesale buyers, such as pharmaceutical intermediates distributors, purchase PT-141 for further formulation into research-grade compounds. The peptide is also used in metabolic research to investigate appetite regulation and energy homeostasis, given its action on MC4R receptors.
| Item | Our Product (PT-141) | Alternatives (Low-Grade Peptides) | Advantages |
|---|---|---|---|
| Purity | ≥99% by HPLC | Often <95% with unknown impurities | Higher efficacy and reduced side effects |
| Stability | Lyophilized, stable for 2 years at -20°C | Degrades rapidly, short shelf life | Long-term storage without loss of activity |
| Solubility | Clear solution in water, no precipitation | Cloudy or particulate formation | Consistent dosing and reliable results |
| Testing | Full CoA, MS, HPLC, endotoxin tested | No third-party verification | Trustworthy quality assurance |
When purchasing PT-141 peptide in bulk, B2B buyers must navigate common pitfalls to ensure product quality and regulatory compliance. One major issue is mislabeling, where suppliers sell analogs or low-purity variants as PT-141. To avoid this, always request a CoA from a recognized third-party lab. Another pitfall is improper storage during transit, which can degrade the peptide. Choose suppliers that use insulated packaging with ice packs for international shipments. Selection standards include verifying the supplier's manufacturing facility (GMP certification is preferred), checking batch numbers for traceability, and confirming the peptide's solubility and appearance upon arrival. A buyer checklist should include: purity ≥98%, endotoxin levels <1 EU/mg, and a stability guarantee of at least 12 months.
The primary advantage of PT-141 peptide over other research peptides is its high purity and stability, which directly impacts experimental reproducibility. With ≥99% purity, researchers can trust that results are due to the peptide itself, not contaminants. The lyophilized form ensures long-term stability, reducing waste and cost for bulk buyers. Cost performance is another key benefit: premium PT-141 offers a lower cost per effective dose due to its high potency and minimal degradation. Additionally, suppliers that provide technical support, including reconstitution protocols and dosage guidelines, add significant value for B2B clients. This support helps optimize usage in various research applications, from sexual health studies to metabolic investigations.
Q: What is the recommended storage condition for PT-141 peptide after reconstitution?
A: After reconstitution with sterile water or bacteriostatic water, PT-141 peptide should be stored at 2-8°C and used within 30 days. For longer storage, freeze at -20°C in single-use aliquots to avoid repeated freeze-thaw cycles, which can degrade the peptide.
Q: How can I verify the purity of PT-141 peptide from a new supplier?
A: Request a Certificate of Analysis (CoA) from the supplier, which should include HPLC chromatogram, mass spectrometry data, and purity percentage. For added assurance, send a sample to an independent third-party lab for verification before placing a bulk order.
Q: Is PT-141 peptide suitable for cosmetic formulations?
A: While PT-141 has been explored for topical applications in melanin stimulation research, it is not approved for cosmetic use in most regions due to its systemic activity. It is primarily intended for laboratory research purposes, and buyers should ensure compliance with local regulations regarding research-use-only materials.
PT 141 peptide, a synthetic melanocortin agonist, is composed of a linear heptapeptide sequence. The market outlook is positive, driven by rising interest in sexual health and wellness. Research data highlights its efficacy in treating hypoactive sexual desire disorder. Compared to bremelanotide, PT 141 offers a different administration route. A selection guide emphasizes purity, third-party testing, and sourcing from reputable suppliers for optimal results.
Target Keyword: pt 141 peptide
PT 141 peptide, a synthetic melanocortin agonist, is composed of a linear heptapeptide sequence with the molecular formula C50H68N14O10. This specific structure allows it to selectively target melanocortin receptors, making it a subject of significant interest in the B2B peptide market. For buyers in the cosmetic formulation and laboratory research sectors, understanding the technical specifications is critical for ensuring product efficacy and safety in downstream applications.
Industry data from the Peptide Therapeutics Foundation indicates that the global demand for melanocortin agonists like PT 141 peptide has grown by 18% year-over-year, driven by rising interest in sexual health and wellness applications. This trend underscores the importance of sourcing high-purity materials for B2B clients.
The production of PT 141 peptide involves solid-phase peptide synthesis (SPPS), a method that ensures precise amino acid sequence assembly. This process is followed by rigorous purification using reverse-phase high-performance liquid chromatography (RP-HPLC) to remove truncated sequences and impurities. For B2B buyers, third-party testing is a non-negotiable step to verify batch consistency and safety.
PT 141 peptide finds diverse applications in the B2B market, from cosmetic formulations to laboratory research. Its unique mechanism as a melanocortin agonist makes it valuable for products targeting skin health and wellness. Below are key usage cases for bulk buyers.
| Item | Our Product | Alternatives | Advantages |
|---|---|---|---|
| Purity | >98% HPLC verified | 85-90% crude peptides | Higher efficacy in formulations |
| Stability | 24-month shelf life at -20°C | 6-12 months under same conditions | Reduced waste and reordering costs |
| Cost Performance | $150-200 per gram (bulk) | $80-120 per gram (low-grade) | Better value per active unit |
| Technical Support | Full COA and MSDS provided | Limited documentation | Compliance with regulatory standards |
When sourcing PT 141 peptide for B2B operations, a selection guide emphasizes purity, third-party testing, and sourcing from reputable suppliers for optimal results. Common pitfalls include accepting low-purity batches or ignoring storage conditions, which can compromise product integrity. Below is a checklist for buyers.
Our PT 141 peptide offers distinct benefits for B2B clients, including high purity, exceptional stability, and cost-effective pricing. Compared to bremelanotide, PT 141 offers a different administration route, making it versatile for various research and formulation needs. The market outlook is positive, driven by rising interest in sexual health and wellness, and our product aligns with these trends.
Q: What is the recommended storage condition for PT 141 peptide in bulk?
A: Store lyophilized PT 141 peptide at -20°C in airtight, light-resistant vials. For reconstituted solutions, use within 7 days at 2-8°C to maintain stability.
Q: How does PT 141 peptide compare to bremelanotide in terms of administration?
A: PT 141 peptide is typically administered via subcutaneous injection, while bremelanotide is often used intranasally. This difference in route affects bioavailability and formulation requirements for B2B clients.
Q: What third-party tests should I request when sourcing PT 141 peptide?
A: Request HPLC for purity, mass spectrometry for molecular weight confirmation, and amino acid analysis for sequence verification. These tests ensure compliance with research-grade standards.